The Wilms’ tumour gene (WT1) has previously been described as an oncogene in several neoplasms of humans, including melanoma, and its expression increases cancer cell proliferation. Recent reports associate the expression of the PPARβ/δ gene (peroxisome proliferator-activated receptor beta/delta) with the downregulation of WT1 in human melanoma and murine melanoma cell lines. The aim of this work was to analyse the expression of WT1 and its association with PPARβ/δ in samples of healthy and melanoma-affected skin of horses by immunohistochemistry. WT1 protein expression was detected in healthy skin, mainly in the epidermis, hair follicle, sebaceous gland and sweat gland, while no expression was observed in equine melanoma tissues. Moreover, it was observed that PPARβ/δ has a basal expression in healthy skin and that it is overexpressed in melanoma. These results were confirmed by a densitometric analysis, where a significant increase of the WT1-positive area was observed in healthy skin (128.66 ± 19.84 pixels 106) compared with that observed in melanoma (1.94 ± 0.04 pixels 106). On the other hand, a positive area with an expression of PPARβ/δ in healthy skin (214.94 ± 11.85 pixels 106) was significantly decreased compared to melanoma (624.86 ± 181.93 pixels 106). These data suggest that there could be a regulation between WT1 and PPARβ/δ in this disease in horses.
Bellone, R. R. (2010): Pleiotropic effects of pigmentation genes in horses. Anim. Genet. 41, 100–110.
Brouillette, J. A., Andrew, J. R. and Venta, P. J. (2000): Estimate of nucleotide diversity in dogs with a pool-and-sequence method. Mamm. Genome 11, 1079–1086.
Burden, K. (2011): Melanomas and their effect on the grey horses. Young Sci. J. 10, 75–81.
Dunning, K. R., Anastasi, M. R., Zhang, V. J., Russell, D. L. and Robker, R. L. (2014): Regulation of fatty acid oxidation in mouse cumulus-oocyte complexes during maturation and modulation by PPAR agonists. PLoS One 9, e87327.
Fleury, C., Bérard, F., Leblond, A., Faure, C., Ganem, N. and Thomas, L. (2000): The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): Epidemiological survey. Pigm. Cell Res. 13, 47–51.
Garrido Ruiz, M. C., Rodríguez Peralto, J. L. and Carrillo Gijón, R. (2010): Comparison of the Protein Expression Profile Between Nevi and Melanoma [in Spanish]. Doctoral Thesis, Universidad Complutense de Madrid Facultad de Medicina, Departamento de Anatomía Patológica, Madrid, Spain. pp. 1–235. ISBN: .
Garza-Rodríguez, O. (2015): Analysis of the Expression of WT1 Gene (Wilm’s tumor) in Equine Melanoma [in Spanish]. MSc Thesis, Universidad Autónoma de Nuevo León, Monterrey, NL.
Ham, S. A., Yoo, T., Hwang, J. S., Kang, E. S., Lee, W. J., Paek, K. S., Park, C., Kim, J.-H., Do, J. T., Lim, D.-S. and Seo, H. G. (2014): Ligand-activated PPARδ modulates the migration and invasion of melanoma cells by regulating Snail expression. Am. J. Cancer Res. 4, 674–682.
Hira, V. V. V., Loncq de Jong, A., Ferro, K., Khurshed, M., Molenaar, R. J. and van Noorden, C. J. F. (2019): Comparison of different methodologies and cryostat versus paraffin sections for chromogenic immunohistochemistry. Acta Histochem.. 121, 125–134.
Lee, C. H., Olson, P., Hevener, A., Mehl, I., Chong, L. W., Olefsky, J. M., Gonzalez, F. J., Ham, J., Kang, H., Peters, J. M. and Evans, R. M. (2006): PPARδ regulates glucose metabolism and insulin sensitivity. Proc. Natl Acad. Sci. U.S.A. 103, 3444–3449.
Michiels, J. F., Perrin, C., Leccia, N., Massi, D., Grimaldi, P. and Wagner, N. (2010): PPARβ activation inhibits melanoma cell proliferation involving repression of the Wilms’ tumor suppressor WT1. Pflügers Arch. – Eur. J. Physiol. 459, 689–703.
Mrowka, C. and Schedl, A. (2000): Wilms’ tumor suppressor gene WT1: From structure to renal pathophysiologic features. J. Am. Soc. Nephrol. 11, S106–S115.
Nakatsuka, S., Oji, Y., Horiuchi, T., Kanda, T., Kitagawa, M., Takeuchi, T., Kawano, K., Kuwae, Y., Yamauchi, A., Okumura, M., Kitamura, Y., Oka, Y., Kawase, I., Sugiyama, H. and Aozasa, K. (2006): Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod. Pathol. 19, 804–814.
Rodríguez-Martín, M. (2008): Targeting the PPARs. Med. Cutan. Iber. Am. (4) 161–163.
Schaffer, P. A., Wobeser, B., Martin, L. E., Dennis, M. M. and Duncan, C. G. (2012): Cutaneous neoplastic lesions of equids in the central United States and Canada: 3,351 biopsy specimens from 3,272 equids (2000–2010). J. Am. Vet. Med. Assoc. 242, 99–104.
Seltenhammer, M. H., Sundström, E., Meisslitzer-Ruppitsch, C., Cejka, P., Kosiuk, J., Neumüller, J., Almeder, M., Majdic, O., Steinberger, P., Losert, U. M., Stöckl, J., Andersson, L., Sölkner, J., Vetterlein, M. and Golovko, A. (2014): Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses. In Vitro Cell. Dev. Biol. Anim. 50, 56–65.
Sutton, R. H. and Coleman, G. T. (1997): Melanoma and the greying horse: A study of the grey horse melanoma, with special reference to prevalence, tumor structure and biology and associated pigment metabolism abnormalities: A report for the rural industries research development corporation. Rural Ind. Res. Develop. Corp. 1–23.
Tyagi, S., Gupta, P., Saini, A. S., Kaushal, C. and Sharma, S. (2011): The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J. Adv. Pharm. Technol. Research (JAPTR) 2, 236–240.
Valentine, B. A. (2006): Survey of equine cutaneous neoplasia in the Pacific Northwest. J. Vet. Diagn. Invest. 18, 123–126.
Wagner, N., Panelos, J., Massi, D. and Wagner, K. D. (2008): The Wilms’ tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch. – Eur. J. Physiol. 455, 839–847.
Wilsher, M. and Cheerala, B. (2007): WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections. Histopathology 51, 605–610.
Young, G., Toretsky, J. A., Campbell, A. B. and Eskenazi, A. E. (2000): Recognition of common childhood malignancies. Am. Fam. Physician. 61, 2144–2154.
Zamora-Avila, D. E., Franco-Molina, M. A., Trejo-Avila, L. M., Rodríguez-Padilla, C., Reséndez-Pérez, D. and Zapata-Benavides, P. (2007): RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Melanoma Res. 17, 341–348.
Zamora-Avila, D. E., Zapata-Benavides, P., Franco-Molina, M. A., Saavedra-Alonso. S., Trejo-Avila, L. M., Reséndez-Pérez, D., Méndez-Vázquez, J. L., Isaias-Badillo, J. and Rodríguez-Padilla, C. (2009): WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth. Canc. Gene Ther. 16, 892–899.